The human gastrointestinal (GI) tract hosts a complex and dynamic microbiota that plays a crucial role in maintaining host health through immune and metabolic functions. This review summarizes current understanding of the development, composition, and impact of the human GI microbiota on gut integrity and host health. The microbiota, which includes bacteria, archaea, and eukaryota, has co-evolved with the host over thousands of years to form a mutually beneficial relationship. The number of microorganisms in the GI tract is estimated to exceed 10^14, surpassing the number of human cells and containing more genomic content than the human genome. The microbiota provides numerous benefits, including strengthening gut integrity, protecting against pathogens, and regulating host immunity. However, dysbiosis, or an altered microbial composition, can lead to disease. Recent studies have shown that the microbiota is influenced by factors such as diet, host genetics, and environmental factors. The composition of the microbiota varies along and across the GI tract, with distinct microbial communities in different regions. The microbiota is also shaped by the host's immune system, which helps to maintain homeostasis by controlling microbial populations. The microbiota plays a key role in the development of the immune system and the production of essential vitamins. It also influences the host's metabolism, including the production of short-chain fatty acids (SCFAs), which have anti-inflammatory and anti-cancer properties. The microbiota is also involved in the development of the gut barrier and the prevention of pathogen colonization. Antibiotics can disrupt the microbiota, leading to the expansion of pathogenic populations. The microbiota is also influenced by factors such as diet, mode of delivery, and environmental factors. The review highlights the importance of understanding the microbiota's role in health and disease, and the need for further research to develop therapeutic strategies to modulate the microbiota in disease.The human gastrointestinal (GI) tract hosts a complex and dynamic microbiota that plays a crucial role in maintaining host health through immune and metabolic functions. This review summarizes current understanding of the development, composition, and impact of the human GI microbiota on gut integrity and host health. The microbiota, which includes bacteria, archaea, and eukaryota, has co-evolved with the host over thousands of years to form a mutually beneficial relationship. The number of microorganisms in the GI tract is estimated to exceed 10^14, surpassing the number of human cells and containing more genomic content than the human genome. The microbiota provides numerous benefits, including strengthening gut integrity, protecting against pathogens, and regulating host immunity. However, dysbiosis, or an altered microbial composition, can lead to disease. Recent studies have shown that the microbiota is influenced by factors such as diet, host genetics, and environmental factors. The composition of the microbiota varies along and across the GI tract, with distinct microbial communities in different regions. The microbiota is also shaped by the host's immune system, which helps to maintain homeostasis by controlling microbial populations. The microbiota plays a key role in the development of the immune system and the production of essential vitamins. It also influences the host's metabolism, including the production of short-chain fatty acids (SCFAs), which have anti-inflammatory and anti-cancer properties. The microbiota is also involved in the development of the gut barrier and the prevention of pathogen colonization. Antibiotics can disrupt the microbiota, leading to the expansion of pathogenic populations. The microbiota is also influenced by factors such as diet, mode of delivery, and environmental factors. The review highlights the importance of understanding the microbiota's role in health and disease, and the need for further research to develop therapeutic strategies to modulate the microbiota in disease.